key: cord-0428386-rc13la9j
authors: Chen, Kai-En; Guo, Qian; Hill, Timothy A.; Cui, Yi; Kendall, Amy K.; Yang, Zhe; Hall, Ryan J.; Healy, Michael D.; Sacharz, Joanna; Norwood, Suzanne J.; Fonseka, Sachini; Xie, Boyang; Reid, Robert C.; Leneva, Natalya; Parton, Robert G.; Ghai, Rajesh; Stroud, David A.; Fairlie, David P.; Suga, Hiroaki; Jackson, Lauren P.; Teasdale, Rohan D.; Passioura, Toby; Collins, Brett M.
title: De novo macrocyclic peptides for inhibiting, stabilising and probing the function of the Retromer endosomal trafficking complex
date: 2021-07-13
journal: bioRxiv
DOI: 10.1101/2020.12.03.410779
sha: a35d611641118295171e08cca6b50c359868f8a2
doc_id: 428386
cord_uid: rc13la9j

The Retromer complex (Vps35-Vps26-Vps29) is essential for endosomal membrane trafficking and signalling. Mutation of Retromer subunit Vps35 causes late-onset Parkinson’s disease, while viral and bacterial pathogens can hijack the complex during cellular infection. To modulate and probe its function we have created a novel series of macrocyclic peptides that bind Retromer with high affinity and specificity. Crystal structures show the majority of cyclic peptides bind to Vps29 via a Pro-Leu-containing sequence, structurally mimicking known interactors such as TBC1D5, and blocking their interaction with Retromer in vitro and in cells. By contrast, macrocyclic peptide RT-L4 binds Retromer at the Vps35-Vps26 interface and is a more effective molecular chaperone than reported small molecules, suggesting a new therapeutic avenue for targeting Retromer. Finally, tagged peptides can be used to probe the cellular localisation of Retromer and its functional interactions in cells, providing novel tools for studying Retromer function.

The Vps29-binding peptides that we have identified mimic the interactions of endogenous and bacterial 147 ligands but bind with higher affinity. We assessed the importance of peptide cyclisation for this increased 148 affinity using a linear version of RT-D1 and found that this reduced the affinity by ~six-fold to 0.76 µM (Fig.   149   S3C ). In addition to the core Pro-Leu di-peptide motif and the cyclic structure, the residues at positions +4 to 150 +7 of the peptides also form extensive contacts with a surface groove composed of Vps29 side chains Val172, 151 Lys173 and Val174 ( Fig. 2D; Fig. S3B ). Again, using RT-D1 as an example, we found that mutations of these 152 residues (positions +4, +5, +7 and +8) to alanine significantly reduced the affinity for Retromer to ~2.2 μM 153 (Fig. S3C) . Interestingly, this interaction network is shifted by 8 Å towards Lys188 in the ctVps29 -RT-D3 154 structure (equivalent to Arg176 in human Vps29), which may explain the weaker binding of ctVps29 to RT-155 D3 compared to human Vps29 ( Fig. 2D; Fig. S3D ). Another noteworthy observation was found in the Vps29 156 -RT-L1 structure, where a potential secondary cyclic peptide binding pocket was identified, surrounded by 157 helix 3 and Ile91 of Vps29 (Fig. S3E) , a region known to be required for Vps35 binding. In this binding pocket, 158 we found two RT-L1 peptides are bound to each other, forming extensive contacts with residues located on 159 helix 3 and adjacent loop region of Vps29 (Fig. S3F) . This binding of RT-L1 to a secondary site in Vps29 is 160 likely due to a crystallisation-induced contact, but it could suggest a potential site for targeting the Vps35 interaction in the future.

164 Vps35 165 One of our initial goals was to identify potential molecular chaperones that can stabilise the Retromer complex, 166 hence we next assessed the impact of the macrocyclic peptides on the thermal stability of Retromer using 167 differential scanning fluorimetry (DSF) (Fig. S4A) . The Vps29-binding peptides RT-D1, RT-D2, RT-D3, L1 and RT-L2 all increased the melting temperature (Tm) of Vps29 upon addition of a 20-fold molar excess 169 (Fig. S4A) , consistent with their high affinities. In contrast however, none of the Vps29-specific macrocyclic 170 peptides had a significant impact on the thermal stability of the trimeric Retromer holo-complex (Fig. S4B) . 171 This suggests that increasing the thermal stability of Vps29 alone is insufficient to enhance the stability of the 172 entire Retromer complex in solution. In contrast, the addition of RT-L4 resulted in a substantial 2°C to 6.5°C 173 enhancement in the Tm of the Retromer holo-complex in a dose-dependent manner ( Fig. 3A; Figs. S4C and 174 S4D). Similarly, the RT-L4 peptide resulted in an 8°C increase in Tm for the Vps26A-Vps351-390 sub-complex, 175 and as expected in control experiments it did not affect the thermal stability of either Vps26A or Vps29 alone 176 (Fig. S4C) . Using mass photometry, we found that the Retromer holo-complex was maintained at its trimeric 177 state upon the addition of cyclic peptides, suggesting that the enhancement in the Tm of the Retromer was not 178 the result of high-order oligomer formation (Fig. S5A) . These results together indicate that RT-L4 stabilizes 179 Retromer through its interaction at the interface between Vps26A and Vps35, possibly by acting as a molecular 180 'staple' between the two subunits. In parallel, we also compared the binding and thermal stability effect of L4 against the previously published Retromer chaperone R55 and its derivative compound 2a (20, 48) . Using 182 24/2/20 9 than RT-L4 (Table S4; Fig. S5B ). While we observed weak binding, we were unable to detect significant 184 improvement in the Tm of Retromer in the presence of either R55 or compound 2a under the same experimental 185 conditions as RT-L4 (Fig. S5C) . Even in the presence of 1 mM R55 (> 300-fold molar excess) little impact on 186 Retromer stability was detectable (Fig. S5D) , although a second unfolding event was observed that might 187 indicate partial stabilisation of the 48) . The difference is likely explained by lower 188 binding affinity of both R55 and compound 2a to Retromer. Our results thus indicate that RT-L4 can act as a 189 potent molecular stabiliser of Retromer in vitro. 190 Next, we sought to map the exact binding region of RT-L4 to better investigate the mechanism of its 191 interaction and how this results in the enhanced thermal-stability of Retromer. Using ITC we found that L4 binds to zRetromer with a Kd of 80 nM, which is highly comparable to human Retromer or the Vps351-390 sub-complex (Table S2; Fig. S6A ). In contrast, RT-L4 binds with lower affinity to ctRetromer with 194 a Kd of 6 µM ( Table S2 ; Fig. S6B ). As our data indicated that RT-L4 binds to a site that is formed by a 195 combined interface on Vps35-Vps26A, streptavidin agarose beads coated with biotinylated to pulldown purified Vps26A-Vps351-390 incorporating several specific point mutations, and this revealed that 197 peptide binding was abolished by a D128R mutation in Vps35 (Fig. 3B) . The Asp128 side-chain is part of a 198 conserved surface adjacent to the Vps35-Vps26A interface (Fig. 3C) , and makes a minor contact with the 199 extended N-terminus of SNX3 when in a ternary complex with the SNX3 adaptor and WF[LV] sequence 200 containing-cargo peptides (where W and F are aromatic and hydrophobic side-chains) (3, 59) . In contrast, L4 contains a number of aromatic residues that could potentially contribute to high affinity binding. Indeed, 202 mutation of any of these residues to alanine shows that they are essential for Retromer interaction (Fig. 3D   203 and 3E). Similarly, the linear form of RT-L4 was unable to bind to Retromer (Fig. 3D) , suggesting both 204 aromatic residues and peptide cyclisation are critical for the interaction. 205 With the multiple attempts to co-crystallize RT-L4 without success, we further explored the site where 206 RT-L4 binds Retromer using single particle cryo-electron microscopy (cryoEM). In previous work, wild-type 207 Retromer was found to form a mixed population of hetetrotrimers and multiple higher order oligomers in 208 vitreous ice, so we used an established mutant called "3KE Retromer" (point mutations E615A/D616A/E617A 209 in Vps35) that favours the heterotrimeric species over higher order oligomers for our analyses (61). We Table S5 ). At the current 212 resolution we detected no structural differences between wild-type heterotrimer (61) and the 3KE mutant. Overall, our cryoEM data shows that there are no gross structural changes in Retromer induced by 217 the RT-L4 peptide, and although not conclusive these reconstructions provide support for our biophysical and 218 mutagenesis data indicating that RT-L4 binds and stabilizes Retromer at the Vps26/Vps35 interface. Higher 219 resolution data will be required however to unambiguously identify specific residues in both Retromer and the 220 peptide that mediate the interaction. 223 Given the high affinity and specificity of the macrocyclic peptides for Retromer, it was critical to assess their 224 potential effects on Retromer's interaction with essential regulatory, accessory and adaptor proteins. We used 225 RT-L4, with its distinct affinity for the Vps26-Vps35 complex, and RT-D3 as a representative Vps29-binding 226 peptide, and tested Retromer binding proteins for which binding mechanisms were known including TBC1D5 Table S6 ). The same inhibitory effect was also observed for the N-terminal 233 region of the bacterial effector RidL (RidL1-236) (Fig. S7A) . In contrast, while the addition of RT-D3 blocked 234 Retromer from interacting with TBC1D5TBC or RidL as would be predicted from their overlapping binding 235 sites, it had no impact on Retromer binding to either SNX27 or SNX3 as assessed in pulldowns and ITC 236 experiments (Figs. 4A, 4C, and 4D). Note that for ITC and pull-down experiments with SNX3, we found it 237 was necessary to include a synthetic peptide corresponding to DMT1-II550-568 containing a WF[LV] cargo motif 238 (where W = an aromatic side-chain and F = a hydrophobic side-chain) (59). In the absence of this peptide we 239 could not detect binding of SNX3 to Retromer, likely because SNX3 and cargo motifs form a co-dependent 240 binding interface with the Retromer complex (3, 59) . To our surprise, the addition of RT-D3 modestly affected 241 Retromer binding to Fam21 C-terminal LFa repeats 19 to 21 (Figs. 4A and 4E), a sequence known to associate 242 with a C-terminal region of Vps35 (22, 65) . It is therefore likely that Vps29 contributes partially to the binding 243 of LFa sequences of Fam21 as previously reported (67), and RT-D3 either directly competes with Fam21 or 244 allosterically affects the Fam21 binding site. These results were further validated using qualitative pulldowns 245 from HeLa cell lysates with biotinylated RT-D3 peptide, where specific loss of TBC1D5 and VARP binding 246 was seen, without any effect on the association of other Retromer ligands SNX27, Fam21, SNX3 and SNX27 247 (Fig. 4F) . Altogether our data indicates RT-D3 can specifically inhibit binding to TBC1D5, and most likely 248 will also compete with other proteins such as VARP and RidL that bind to the same conserved hydrophobic 249 cavity on Vps29. 250 In contrast to RT-D3, we found that the RT-L4 peptide had little negative impact on the interaction of 251 Retromer with any ligands tested. In GST-pulldowns using purified proteins or using biotinylated peptides and 252 HeLa lysates Retromer was able to interact with TBC1D5, VARP, Fam21, SNX27 and the SNX3-DMT1-II 253 complex in the presence of RT-L4 (Figs. 4A and 4E). Interestingly, by ITC we found that the affinity and 254 enthalpy of binding between Retromer for either SNX27PDZ, TBC1D5TBC, or Fam21R19-R21 were substantially 255 improved by the addition of RT-L4 (Figs. 4B, 4D and 4E; Fig. S7B ; Table S6 ). The enhancement of Retromer 256 binding to TBC1D5TBC by RT-L4, also led to a slight improvement of GAP-stimulated GTP hydrolysis of 257 Rab7a ( Fig. S7C and S7D ). In the case of SNX27, the binding between SNX27PDZ and PDZ-dependent cargo 258 peptide, PTHR586-593, was also further improved to a Kd of 700 nM by the presence of RT-L4 (Fig. 4G) . This 259 suggests that the stabilization of Retromer by RT-L4 may be able to enhance binding to some of its key 260 partners, promote GAP activity, and possibly also improve cargo recognition. However, we did observe a 261 modest reduction in the binding affinity of Retromer for the SNX3-DMT1-II complex from 154 μM to 230 262 μM in the presence of RT-L4 ( Fig. 4C affinity observed by ITC (Fig. S7G) . In summary, peptides binding to Vps29 have a strong and specific impact 275 on a subset of Retromer-associated proteins including TBC1D5 and VARP, without affecting interactions that 276 occur near the Vps35-Vps26 interface (Fig. 4I) . The stabilising RT-L4 peptide does not prevent binding of 277 any known ligands (Fig. 4I) , which is an important property of a potential molecular chaperone, although it 278 does have subtle effects on these interactions depending on their respective binding sites. During our analyses of RT-L4 we noted that it showed a lower binding affinity for the paralogous Vps26B-283 Vps351-390 subcomplex when compared to Vps26A-Vps351-390 ( Fig. 5A; Table S2 ). According to the sequence 284 alignment of Vps26, the residues responsible for Vps35 interaction are highly conserved (Figs. S8A and S8B), 285 while the extended C-terminal tails (residues 298 to 327 in Vps26A) are highly divergent apart from the 286 QRF/YE motif (Fig 5B; Fig. S8A ). Strikingly when the disordered C-terminal domains of either Vps26A or 287 Vps26B are removed (Vps26ADC and Vps26BDC respectively) the binding affinity for RT-L4 is increased to 288 ~40 nM Kd and is now identical for both sub-complexes (Fig. 5A) . We also find a similar improved affinity of 289 RT-L4 for C. thermophilum Retromer when the tail of Vps26 is removed (Fig. S9) . This shows that the C-290 terminal tails of Vps26A and Vps26B have an autoinhibitory effect on binding to RT-L4, with the Vps26B C-291 terminus inhibiting the interaction more strongly.

Given that the RT-L4 peptide also subtly affects binding of Retromer to SNX3 and cargos, we were 293 interested to determine whether the C-terminal tails of Vps26 might also influence SNX3 interactions. 294 Intriguingly, SNX3 (in the presence of DMT1-II cargo) binds to Vps26ADC-Vps351-390 with a significantly 295 increased affinity compared to full-length Vps26A-Vps351-390 ( Fig. 5C; Table S7 ). This suggests that there is 296 a self-association of the C-terminal tail that weakens the SNX3-cargo interaction. Previous proteomics have 297 shown that the C-terminal disordered sequences of human and mouse Vps26A and Vps26B can be 298 phosphorylated, although the role of these post-translational modifications (PTMs) and their regulation has 299 not been studied (69) (Fig. 5B) . We engineered a Vps26A variant with three phosphomimetic mutations in its 300 C-terminal tail and tested the affinity of the Vps351-390/Vps26A phosphomimic complex for SNX3 in the 301 presence of DMT1-II by ITC (Fig. 5C) 312 With established mechanisms of binding in vitro we sought to assess the basic utility of these macrocyclic 313 peptides as novel molecular tools for the study of Retromer. In the first instance we examined their use as 314 fluorescent probes of Retromer localisation in cells (Fig. 6) . As the peptides were not membrane permeable 315 for cellular uptake we used a reversible cell permeabilization approach with the pore-forming bacterial toxin 316 Streptolysin O (SLO) (71). After permeabilization cells were treated with FITC-labelled RT-D3 and RT-L4 317 and then processed for imaging and co-labelling with specific endosomal markers. In the absence of SLO 318 permeabilization no intracellular fluorescence was detected for the FITC-labelled peptides indicating they are 319 not crossing the membrane or being non-specifically internalised into the lumen of endosomal compartments 320 (Fig. 6A) . In permeabilised cells however, both FITC-labelled RT-D3 and RT-L4 were recruited to endosomal 321 structures labelled with SNX1 (Fig. 6A) . Using Airyscan super-resolution microscopy we found that the 322 peptides also co-labelled endosomal structures marked with mCherry-tagged Vps35 (Fig. 6B) . Lastly, we 323 examined the impact of the peptides on the endosomal recruitment of TBC1D5, which has previously been 324 shown to depend on interaction with Retromer (40, 43, 44, 56, 72) . As expected, addition of unlabelled RT-325 L4 had no discernible effect on TBC1D5 localisation; however, RT-D3, which binds to the same site on Vps29 326 as TBC1D5, caused significant dispersal of TBC1D5 from endosomal structures (Fig. 6C) . In orthogonal 327 experiments we adapted an electroporation approach to deliver peptides to cells (73), and observed a similar 328 inhibition of Retromer-dependent TBC1D5 localisation using electroporation (Fig. S10) 336 In this work the versatile RaPID screen was used to identify a series of potent Retromer-targeting macrocyclic 337 peptides. These bind with high affinity and specificity to Retromer using two distinct evolutionarily conserved 338 binding sites on either Vps29, or at the interface between Vps26 and Vps35. The cyclic peptides in the inhibitor 339 sub-group (RT-D1, RT-D2, RT-D3, RT-L1 and RT-L2) reveal strong binding through the highly conserved 340 surface groove of Vps29, lying on the opposite surface to that bound by the Vps35 subunit. Detailed structural 341 analyses showed that these cyclic peptide inhibitors all form a β-hairpin configuration with a core Pro-Leu 342 motif. These Vps29-binding cyclic peptides are effective at blocking association with TBC1D5, VARP and 343 the bacterial hijacking molecule RidL, which are known to bind the same site using a similar b-hairpin structure 344 (40, 43, 44) . It is intriguing that all of the Vps29-binding peptides have been selected for the presence of this 345 Pro-Leu dipeptide, and that this peptide has also evolved to mediate binding of endogenous ligands of the 346 Retromer complex such as TBC1D5, VARP and RidL. The de novo macrocyclic peptide screening has 347 therefore inadvertently identified an evolutionarily conserved binding mechanism, and interestingly previous 348 screens of BET domain-binding peptides also uncovered sequence preferences that partly mimicked known 349 endogenous ligands (74). Given that Vps29 is also a component of the Retriever complex, a Retromer-related 350 assembly containing homologous subunits Vps35L and Vps26C (75, 76) , these cyclic peptide inhibitors may 351 also provide tools for studies of Retriever. However, known Retromer interactors such as TBC1D5 or VARP 352 that depend on Vps29 for association have not been detected in Retriever interactomes (75), so whether the 353 same binding site in Vps29 is accessible within the Retriever complex remains to be confirmed.

Among the identified macrocyclic peptides RT-L4 binds specifically to the interface between the N-355 terminal domain of Vps35 and the C-terminal sub-domain of Vps26 and is the sole molecule to show a 356 significant ability to stabilise the Retromer complex. In the recent cryoEM structure of mammalian Retromer 357 it was found that Vps26 and the N-terminal portion of Vps35 exhibit substantial flexibility compared with 358 other regions of the complex (61). We speculate that the improved thermal stability of Retromer in the presence 359 of RT-L4 may be partly due to reduced flexibility in these two subunits. Importantly, the RT-L4 peptide did 360 not inhibit the binding of Retromer to its essential interacting partners including SNX27, Fam21, TBC1D5 and 368 The series of macrocyclic peptides discovered here provide novel molecular probes for the study of Retromer 369 and endosomal trafficking. Firstly, using a simple reversible permeabilization approach, we have successfully 370 delivered the cyclic peptides RT-D3 and RT-L4 into cells and find they are specifically targeted to the 371 Retromer-positive endosomal structures. Thus, the peptides can be used to examine endogenous Retromer 372 localisation in situ and could feasibly be used to study Retromer in live cells or using super-resolution 373 approaches with different types of fluorescent dyes apart from the simple FITC labelling strategy used here.

The RT-D3 peptide also impacts recruitment of proteins such as TBC1D5 that depend on binding to the Vps29 375 subunit of the complex, and therefore could be used to probe the impact of acutely disrupting this interaction 376 in the future. In addition to studying the localisation of Retromer, the RT-L4 peptide provided a highly specific 377 substrate for purification of the Retromer complex from cells, and in the future could be useful for proteomic 378 studies of Retromer in diverse cells, tissues, and organisms. We also envisage that these peptides will provide 379 tools for enhancing Retromer stability for future structural studies of its interactions with accessory and 380 regulatory proteins by cryoEM and X-ray crystallography.

Our studies of the RT-L4 peptide binding to the Vps26-Vps35 interface revealed an autoinhibitory role 382 for the C-terminus of the Vps26A and Vps26B paralogues. Removal of their divergent C-terminal tails 383 significantly increased the affinity of both Retromer complexes for the RT-L4 peptide to similar levels, leading 384 us to then test the impact of the Vps26A and Vps26B tail domains on binding to the SNX3-DMT1-II cargo-385 adaptor complex, a native ligand that engages Retromer at a similar location. Again, removal of the C-terminal 386 disordered domains significantly improved the affinity of Retromer for SNX3-DMT1-II, confirming their 387 autoinhibitory activity has a functional importance. Furthermore, this may be regulated by phosphorylation of 388 the Vps26A and Vps26B tails, as phosphomimetic mutants have a higher affinity for SNX3-DMT1-II than the 389 wild-type proteins. Since the discovery of the Vps26B paralogue of Vps26A it was clear that the most 390 significant difference between the two proteins was the sequence of their C-terminal domains (78, 79) . Later 391 it was shown that Vps26A but not Vps26B Retromer bound to the SNX3-dependent cargo CI-MPR, however, 392 CI-MPR binding and trafficking by Vps26B was restored when its tail was deleted (70). Our data demonstrates 393 a direct role for both the Vps26A and Vps26B tails in negatively regulating the binding of SNX3-cargo in 394 vitro, with the Vps26B tail possessing a more potent autoinhibitory sequence than that of Vps26A. This 395 suggests that an activating switch such as phosphorylation of Vps26 proteins or binding of another regulatory 396 protein may promote the recruitment of SNX3-cargo complexes by Retromer in cells, although the specific 397 nature of this switch remains to be determined. increasing interest in developing molecules for both inhibition and enhancement of Retromer activity in these 404 processes (11, 80, 81) . As shown previously, peptides that target Retromer and compete with the viral L2 405 protein can reduce HPV infection in cell and animal models (38, 45, 82) , while a small molecule with Retromer 406 chaperoning activity can reduce cellular accumulation of toxic material causing neurodegeneration (33, (46) (47) (48) (49) (50) (51) (83) (84) (85) (86) (87) . However, these peptides and small molecules have only a relatively low affinity for Retromer, and 408 their specificities and pharmacological profiles are essentially unknown. Retromer, notable hurdles will include cell permeability, oral availability, and an ability to cross the blood 425 brain barrier when targeting neurological diseases. However, new approaches show promise in overcoming 426 these barriers, including the use of non-standard amino acids with novel activities and solubility profiles, 427 coupling to various cell-targeting peptides, and novel delivery methods (91-94). Alternatively, the peptides 428 discovered here could provide the basis for competitive screening for drug-like molecules that target the same 429 binding sites.

In summary, we have identified a series of Retromer-targeting macrocyclic peptides and demonstrate 431 their potential for Retromer inhibition and activation based on a comprehensive understanding of their different 432 mechanisms of action. They will be a valuable resource for the study of Retromer function at the cellular and 433 molecular level and represent promising leads for the targeting of Retromer in a variety of diseases caused by 434 dysregulation or disruption of the endosomal membrane trafficking system. For bacterial expression, Retromer constructs encoding full-length human and zebrafish Vps29,

Vps26A and Vps35 were cloned into either pET28a and pGEX4T-2 vectors as described previously (60, 96). 456 Chaetomium thermophilum Vps29, Vps26 and Vps35 were also cloned using protocol described previously 457 (58). In all cases, Vps26A was cloned as a N-terminal His6-tag fusion protein and Vps29 was cloned into 458 pGEX4T-2 vector as a cleavable N-terminal GST fusion protein. For mouse Vps26B, full-length cDNA was 459 inserted into pMW172Kan vector (78) . For the truncation constructs, the DNA sequence encoding the N-460 terminal part of Vps35 (Vps351-172, Vps351-224 and Vps351-390) was cloned into pGEX4T-2 vector. Vps26 ∆C-461 term. tail (∆C) constructs (Vps26A9-298 and Vps26B7-296) were cloned into pET28a vector containing His6-tag. pneumophila effector RidL residues 1 to 236 was also cloned into the pGEX4T2 vector. Full-length human 471 Rab7a was cloned into pET28a vector. Site-directed mutagenesis was performed to generate mutant constructs 472 with custom-designed primers. All constructs were verified using DNA sequencing. 

For the second and subsequent rounds of selection, the translation reaction was scaled down to 2.5 µL 487 total volume, and 6 iterative counter-selections using uncoated beads were conducted prior to affinity selection Fmoc-based chemistry on a Syro I peptide synthesizer (Biotage). Fmoc-protected amino acid (6 eq.), (2-(1H-494 benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU, 6 eq.), hydroxybenzotriazole 495 (HOBt, 6 eq.) and disopropylethylamine (DIPEA, 12 eq.) with 30 min coupling cycles. Deprotection of fmoc 496 was achieved with 40% piperidine/DMF for 1 × 3 min. then 1 x 12 min. Chloroacetic acid was coupled 497 manually after the final deprotection using the same conditions.

Linear peptides were cleaved from resin with TFA/TIS/H2O/EDT (92.5:2.5:2.5:2.5) over 2 h. Crude 499 peptides were precipitated and washed (5x cold Et2O), redissolved in DMSO, and cyclized by adding DIPEA 500 until basic followed by incubating at room temperature. Cyclic peptides were acidified, diluted to 50% DMSO 501 with water and purified by RP-HPLC using a Chromolith C18 column with a gradient of 10 to 70% buffer B 502 (99.9% CH3CN/0.1% TFA in buffer A, 0.1% TFA in water) over 40 min and lyophilized, before the TFA salt 503 was exchanged to HCl by triplicate lyophilization from 5 mM HCl aq. Biotin and FITC labelled peptides were synthesized (100 µM scale) on Rink Amide MBHA resin (0.6 mmol/g) 507 using Fmoc-based chemistry and a peptide synthesizer (Symphony, Protein Technologies) Fmoc -Lys(Mtt)-508 OH in position 1. Fmoc-protected amino acid (4 eq.), 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3 509 tetramethylaminium hexafluorophosphate (HCTU, 4 eq.), and disopropylethylamine (DIPEA, 4 eq.) were used 510 in 2 × 30 min coupling cycles. Fmoc deprotection was achieved by treatment with 1:2 piperidine/DMF for 2 511 × 3 min. Chloroacetic acid was coupled manually after the final deprotection using chloroacetic acid (4 eq.) 512 and HATU (4 eq.), and DIPEA (4 eq.) in N,N-dimethylformamide (DMF). Selective side-chain deprotection 513 of the methyl trityl (Mtt) group on lysine was achieved using 3% TFA in dichloromethane (DCM) (5 ´ 2 min).

Biotin was coupled using biotin 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl 515 uraniumhexafluorophosphate methanaminium (HATU, 2 eq.) and DIPEA in DMF. FITC was coupled using 516 FITC (2 eq.) and DIPEA. 

Images were processed using ImageJ software. Colocalization analysis was performed as described 562 previously (100). In brief, single cells were segregated from fields of view by generating regions of interest, 563 cropped, split into separated channels, and applied for threshold processing. Colocalization analysis was 564 conducted on three independent experiments and represented as Pearson's correlation coefficient.

Colocalization values were exported to R studio and tabulated accordingly. Cells grown on coverslips were fixed with 4% PFA in PBS for 15 min followed by permeablisation 578 and blocking with 0.1% saponin in 2% BSA/PBS for 20 min. Cells were then labelled with the diluted goat 579 polyclonal TBC1D5 antibody (1:100) and rabbit polyclonal Vps26A antibody (1:500) in 0.1% saponin 580 followed by the corresponding fluorescently-conjugated secondary antibodies for 1 h at room temperature.

Coverslips were mounted on glass microscope slides using the Fluorescence Mounting Medium (DAKO), and 582 the images were taken using a Leica DMi8 SP8 inverted confocal microscope equipped a 63x Plan 583 Apochromatic 1.4 NA oil objective. Images were processed using Fiji/Image J software and the co-localization 584 analysis was performed using the Fiji/Image J EzColocalization plugin. In brief, ~ 60 individual cells for each 585 condition were randomly selected and cropped to generate and record regions of interest (ROI). The selected 586 ROI was then split into the separate channels and threshold applied before co-localization analysis by Pearson's 587 correlation coefficient. Statistical analysis and graph generation were performed using Prism9 (GraphPad) 588 software. Error bars on the graphs represent ± SEM. All p values were calculated using a Student's t test and 589 p < 0.05 was considered as statistically significant. His-SNX27, GST-RidL1-236 and His-Rab7a were performed using similar methods as described previously (56 Retromer. For, His-tagged SNX27 and His-Rab7a, the fractions eluted from Talon® resin was further purified 619 SEC directly using the same buffer as described above. Similarly, the GST-tagged Fam21R19-R21 eluted from 620 Glutathione sepharose was directly injected into SEC for final purification.

Retromer 3KE construct design, expression, and purification has previously been described (61). Table S3 . Sequence conservation was based on a T-Coffee multiple sequence alignment (106) and calculated 697 using the ConSurf Server (107). Structure comparison was analysed using DALI (108) and molecular figures 698 were generated using PyMOL. To ensure that RT-L4 binds specifically only to Retromer but not the accessory proteins, 90 μM of RT-L4 was 723 titrated into 7 μM Retromer, TBC1D5TBC, SNX3 or SNX27 using buffer described above. Retromer data varied between -0.8 and -4.7 μm. was used for all image processing unless 797 otherwise indicated.

Retromer/RT-L4 processing. Micrographs were autopicked using a 20Å low-pass filtered 3D model that had 800 been produced in early rounds of processing, and this template-based autopicking identified 968,806 particles.

Multiple rounds of 2D classification yielded 171,270 particles suitable to continue to 3D classification. The 802 same 3D model used for autopicking was filtered to 60Å and used as an initial model for 3D classification.

The particles underwent multiple rounds of CTF refinement and Bayesian polishing to produce a final set of Statistical analysis was completed in R studio using dplyr, ggplot2, ggpubr packages. Error bars on graphs 849 were represented as the standard error of the mean (± SEM). P values were calculated using the two-tailed 850 Student's t-test. P < 0.05 was considered as significant. showing that addition of α-helix 8 and 9 of Vps35 (residues 173 to 224) contributes to RT-L4 binding affinity 894 but is not essential for interaction. All ITC graphs represent the integrated and normalized data fit with 1 to 1 895 ratio binding. The binding affinity (Kd) is given as mean of at least three independent experiments (Table S2) . 

Unprocessed images of all blots in this study. Co.

Cyclic peptides from initial screen RT-D1 Ac-yIIDTPLGVFLSSLKRC-NH2 1490 1963 RT-D2 Ac-yTTIYWTPLGTFPRIRC-NH2 8480 2126.9 

RT-D1 130 ± 9 -11.5 ± 0.5 -9.4 ± 0.08 2.1 ± 0.6 RT-D2 53 ± 6 -9.7 ± 1.6 -9.9 ± 0.08 0.5 ± 0.2 RT-D3 25 ± 1 -13.4 ± 1.4 -10.4 ± 0.06 3.9 ± 0.1 RT-L1 96 ± 1 -11.0 ± 0.9 -9.5 ± 0.06 1.4 ± 0.9

RT-L2 852 ± 14 -16.0 ± 0.7 -8.2 ± 0.06 7.7 ± 0.7 RT-L4 273 ± 7 -7.0 ± 0. RT-D1 95 ± 1 -14.2 ± 0.3 -9.5 ± 0.06 4.6 ± 0.3 RT-D2 64 ± 1 -11.6 ± 0.1 -9.8 ± 0.08 1.7 ± 0.1 RT-D3 8 ± 2 -17.4 ± 1.4 -11.1 ± 0.21 6.4 ± 1.2 RT-L1 64 ± 5 -13.0 ± 1.1 -9.8 ± 0.08 3.2 ± 1.0 RT-L2 783 ± 7 -9.1 ± 1.6 -8.4 ± 0.06 1.6 ± 0.9

RT-D1 106 ± 4 -10.5 ± 0.4 -9.5 ± 0.09 0.9 ± 0.3 RT-D2 65 ± 5 -11.2 ± 1.0 -9.8 ± 0.07 1.4 ± 0.9

RT-D3 29 ± 2 -11.6 ± 1.3 -10.3 ± 0.08 2.4 ± 1.1 RT-L1 90 ± 3 -7.9 ± 1.2 -9.6 ± 0.07 1.8 ± 1.0 RT-L2 763 ± 12 -8.7 ± 1.7 -8.4 ± 0.08 2.1 ± 1.1

Vps26A_Vps351-390 : RT-L4 165 ± 8 -6.8 ± 1.2 -9.2 ± 0.06 -2.5 ± 1.2 Vps26B_Vps351-390 : RT-L4 491 ± 27 -2.7 ± 1.2 -8.6 ± 0.10 -5.4 ± 0.4

Vps26A_Vps351-224 : RT-L4 222 ± 4 -7.0 ± 1.7 -9.1 ± 0.11 -2.1 ± 1.7

Vps26A_Vps351-172 : RT-L4 339 ± 7 -6.3 ± 2.5 -8.8 ± 0.10 -2.5 ± 2.5

Vps26A9-298_Vps351-390 : RT-L4

(Δ C-term. tail complex) 33 ± 2 -11.9 ± 1.0 -10.2 ± 0.07 1.7 ± 1.0

RT-D1, D2, D3, L1, L2, L4 No binding detected zfRetromer RT-L4 88 ± 11 -6.9 ± 1.8 -9.6 ± 0.08 -2.6 ± 2.0 ctRetromer RT-L4 5030 ± 900 -7.4 ± 0.3 -7.3 ± 0.10 -2.7 ± 1.9

ctRetromer ∆C-term. tail

1770 ± 170 -6.0 ± 0.7 -7.9 ± 0.06 -1.9 ± 0.7

RT-D2 135 ± 3 -10.5 ± 1.0 -9.3 ± 0.08 1.1 ± 0.9

RT-D3 603 ± 6 -7.4 ± 0.3 -8.5 ± 0.07 -0.9 ± 0.1 1095 1096 

18.2 ± 5.0 -0.8 ± 0.3 -6.5 ± 0.2 -5.7 ± 0.5 Compound 2a 8.3 ± 0.8 -1.1 ± 0.9 -6.9 ± 0.05 -5.8 ± 1.0 

Retromer + DMSO (Native) 0.37 ± 0.02 -2.5 ± 0.8 -8.8 ± 0.03 -6.2 ± 0.8

Retromer + RT-L4 0.19 ± 0.01 -5.7 ± 0.1 -9.2 ± 0.06 -3.5 ± 0.1

Retromer + DMSO (Native) 13.0 ± 0.5 -1.1 ± 0.1 -6.7 ± 0.03 -5.6 ± 0.2

Retromer + RT-D3 15.1 ± 0.4 -1.2 ± 0.3 -6.6 ± 0.08 -5.4 ± 0.2 Retromer + RT-L4 8.2 ± 1.0 -5.5 ± 0.3 -6.9 ± 0.07 -1.4 ± 0.4

mSNX27PDZ 5.2 ± 0.4 -10.6 ± 0.4 -7.2 ± 0.05 3.3 ± 0.4

Retromer + mSNX27PDZ 2.4 ± 0.3 -11.1 ± 1.8 -7.7 ± 0.08 3.5 ± 1.9

Retromer + mSNX27PDZ + RT-L4 0.7 ± 0.1 -12.5 ± 0.6 -8.4 ± 0.05 4.3 ± 0.3

Retromer + DMT1 * + DMSO (Native) 154.0 ± 25 -32.4 ± 9.8 -5.2 ± 0.14 27.1 ± 9.8

Retromer + DMT1 * + RT-D3 164.0 ± 3 -33.2 ± 0.4 -5.2 ± 0.02 28.0 ± 0.4

Retromer + DMT1 * + RT-L4 230.0 ± 14 -14.0 ± 0.6 -5.0 ± 0.03 9.0 ± 0.6

Retromer + DMSO (Native) 10.6 ± 0.7 -16.5 ± 0.6 -6.8 ± 0.04 9.8 ± 0.9

Retromer + RT-D3 25.8 ± 0.5 -9.3 ± 3.3 -6.3 ± 0.02 4.0 ± 1.9

Retromer + RT-L4 2.8 ± 0.8 -26.0 ± 1.6 -7.5 ± 0.02 18.4 ± 1.8

Retromer + DMSO (Native) 0.20 ± 0.02 -5.2 ± 0.9 -9.2 ± 0.07 -4.0 ± 1.0

Retromer + RT-D3 41.1 ± 1.8 -4.6 ± 1.3 -5.9 ± 0.02 -1.4 ± 1.3 DMT1* corresponds to DMT1-II550-568. Vps26A -Vps351-390 -CIMPR2347-2376 : SNX3 Native 201 ± 9 -11.8 ± 0.9 -5.1 ± 0.03 6.6 ± 0.8 of Vps35 (residues 173 to 224) contributes to RT-L4 binding affinity but is not essential for interaction. All ITC graphs represent the integrated and normalized data fit with 1 to 1 ratio binding. The binding affinity (Kd) is given as mean of at least three independent experiments (Table S2) RT-L4 Y10A/Y12A

Vps35 Vps29

Retromer (apo form)

Additional density Vps26 Vps35

Vps29 RT-L4 D128 B R e s in + R T -L 4 In p u t Vps35 alone Vps35 E96R R e s in + R T -L 4 In p u t R e s in + R T -L 4 In p u t R e s in + R T -L 4 In p u t R e s in + R T -L 4 In p u t R e s in + R T -L 4 In p u t R e s in + R T -L 4 In p u t Vps35 1-390 RT-L4 

8.61 x 10 5 1.24 x 10 6 3.38 x 10 6 9.03 x 10 5 6.52 x 10 5 6.71 Retromer and RT-L4 shows enhancement of GAP-stimuated GTPase activity of Rab7a over TBC1D5 alone. Two-tailed Student's t-test was utilized to determine the statistical significance (n=3). ****, P < 0.0001; *, P<0.05, ns, not significant. (E) Liposome-binding assay of SNX3 and Retromer using Folch I liposomes containing 10% PtdIns(3)P and 10% N-terminal palmitoylated CIMPR2347-2376 peptide. (F) Liposome-binding assay of Retromer and SNX3 mixture as in (E) except Folch I liposomes contain only 10% PtdIns(3)P without the CI-MPR cargo. Retromer binds only weakly to Folch liposomes in the absence of either SNX3 or cargo sequence. In all three SDS-PAGE gels, "S" indicates unbound supernatant and "P" indicates bound pellet after ultracentrifugation. (G) ITC measurement of SNX3 with Vps26A -Vps351-390 subcomplex in the presence of CIMPR2347-2376 cargo peptide. The graph represents the integrated and normalized data fit with a 1 to 1 binding ratio. The binding affinity (Kd) is given as mean of three independent experiments. Figure S10 . Electroporation of RT-D3 inhibits Retromer-dependent endosomal localisation of TBC1D5. (A) HeLa cells were electroporated with either RT-D3 peptide or scrambled RT-D3 as a negative control. Electroporated cells were recovered for 16 h, fixed and then labelled for endogenous TBC1D5 (cyan) and Vps26A (magenta). In a large proportion of cells (indicated by dashed areas) the endosomal colocalisation of TBC1D5 with Vps26A was significantly reduced. (B) The colocalization between TBC1D5 and SNX1 was quantified by Pearson's correlation coefficient (means ± SEM). Two-tailed Student's t-test was used to determine the statistical significance (n=3). ****, P < 0.0001; ns, not significant.

Modified cyclic peptides RT-D1 L7E

Ac-yIIDTPEGVFLSSLKRC-NH2

To degrade or not to degrade: mechanisms and significance of endocytic 1115 recycling

Towards a molecular understanding of endosomal 1117 trafficking by Retromer and Retriever

Recognising the signals for endosomal trafficking

Retromer: a master conductor of endosome sorting. Cold Spring Harb 1121

The retromer, sorting nexins and the plant endomembrane protein 1123 trafficking

Retrograde trafficking and plasma membrane recycling pathways of the budding 1125 yeast Saccharomyces cerevisiae

Retromer and Its Role in Regulating Signaling at Endosomes. Prog Mol Subcell 1127

A membrane coat complex essential for endosome-to-1129 Golgi retrograde transport in yeast

The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases

The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting 1133 function of retromer

Retromer in Alzheimer disease, Parkinson disease and other neurological 1135 disorders

VPS35 mutations in Parkinson disease

VPS35, the Retromer Complex and Parkinson's Disease

Mutation in VPS35 associated with Parkinson's disease impairs WASH complex 1141 association and inhibits autophagy

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-1143 onset Parkinson disease

Model-guided microarray implicates the retromer complex in Alzheimer's disease

Impaired axonal retrograde trafficking of the 1147 retromer complex augments lysosomal deficits in Alzheimer's disease neurons

Identification of Alzheimer disease-associated variants in genes that regulate 1150 retromer function

VPS35 haploinsufficiency increases Alzheimer's disease neuropathology

Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral 1154 Sclerosis

The emerging role of retromer in neuroprotection

Retromer binding to FAM21 and the WASH complex is perturbed by the 1158 Parkinson disease-linked VPS35(D620N) mutation

Structural Features and Binding Modes of Thioether-1160

Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid 1162 precursor protein sorting and processing

Atypical parkinsonism-associated retromer mutant alters endosomal sorting of 1164 specific cargo proteins

Retromer-dependent neurotransmitter receptor trafficking to synapses is altered 1166 by the Parkinson's disease VPS35 mutation p.D620N

VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of

Receptor of Chaperone-Mediated Autophagy That Is Critical for alpha-Synuclein 1169

Degradation and Prevention of Pathogenesis of Parkinson's Disease

Control of RAB7 activity and localization through the retromer-TBC1D5 1172 complex enables RAB7-dependent mitophagy

VPS35 Deficiency or Mutation Causes Dopaminergic Neuronal Loss by Impairing 1174

Mitochondrial Fusion and Function

A conserved retromer sorting motif is essential for 1176 mitochondrial DLP1 recycling by VPS35 in Parkinson's disease model

Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by 1179 recycling DLP1 complexes

Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology 1181 and dopaminergic neurodegeneration

Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal 1183 Association of Retromer and Induces alpha-Synuclein Aggregation

Coupling of terminal differentiation deficit with neurodegenerative pathology in

Vps35-deficient pyramidal neurons

Identification of host 1188 trafficking genes required for HIV-1 virological synapse formation in dendritic cells

Retromer regulates HIV-1 envelope glycoprotein 1191 trafficking and incorporation into virions

Intracellular Transport of Vaccinia Virus in HeLa Cells Requires WASH

VPEF/FAM21-Retromer Complexes and Recycling Molecules Rab11 and Rab22

Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 1196 mediates endosome exit during viral infection

Identification of Required Host Factors for SARS-CoV-2 Infection in Human 1198 Cells

Structural insights into Legionella RidL-Vps29 retromer subunit interaction 1200 reveal displacement of the regulator TBC1D5

The Legionella effector RidL inhibits retrograde trafficking to promote intracellular 1202 replication

Actin polymerization in the endosomal pathway, but not 1204 on the Coxiella-containing vacuole, is essential for pathogen growth

Molecular mechanism for the subversion of the retromer coat by the 1207

Mechanism of inhibition of retromer transport by the bacterial effector RidL

Cell-Penetrating Peptide

Mediates Intracellular Membrane Passage of Human Papillomavirus L2 Protein to Trigger 1212

Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of 1214 ageing

Endosomal Traffic Jams Represent a 1216

Pathogenic Hub and Therapeutic Target in Alzheimer's Disease

Pharmacological chaperones stabilize retromer to limit APP processing

A pharmacological chaperone improves 1221 memory by reducing Abeta and tau neuropathology in a mouse model with plaques and tangles

Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35

Similar to alpha-Synuclein Gain

Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's

Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein

Construction and screening of vast libraries of natural product-like 1230 macrocyclic peptides using in vitro display technologies

Ribosomal production and in vitro selection of natural product-like 1232 peptidomimetics: the FIT and RaPID systems

A RaPID way to discover nonstandard macrocyclic peptide modulators of 1234 drug targets

Max-Bergmann award lecture:A RaPID way to discover bioactive nonstandard peptides 1236 assisted by the flexizyme and FIT systems

Structural and mechanistic insights into regulation of the retromer coat by TBC1d5

Functional architecture of the retromer cargo-recognition complex

Structure of the membrane-assembled retromer coat determined by cryo-electron 1242 tomography

Structural Mechanism for Cargo Recognition by the Retromer Complex

Assembly and solution structure of the core retromer protein complex

Mammalian Retromer Is an Adaptable Scaffold for Cargo Sorting from

VARP is recruited on to endosomes by direct interaction with retromer, where 1250 together they function in export to the cell surface

Mechanism and evolution of the Zn-fingernail required for interaction 1252 of VARP with VPS29

Mechanism and evolution of the Zn-fingernail required for interaction 1254 of VARP with VPS29

Multiple repeat elements within the FAM21 tail 1256 link the WASH actin regulatory complex to the retromer

A unique PDZ domain and arrestin-like fold interaction reveals mechanistic details 1258 of endocytic recycling by SNX27-retromer

Endosomal recruitment of the WASH complex: active sequences and mutations 1260 impairing interaction with the retromer

A mechanism for retromer endosomal coat complex assembly with cargo

PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids 1264 Res

Vps26A and Vps26B subunits define distinct retromer complexes

Labeling proteins inside living cells using external fluorophores for microscopy

The cargo-selective retromer complex is a recruiting hub for protein complexes 1270 that regulate endosomal tubule dynamics

Electroporated recombinant proteins as tools for in vivo functional complementation, 1272 imaging and chemical biology

Cyclic peptides can engage a single binding pocket through multiple, entirely 1274 divergent modes

Retriever is a multiprotein complex for retromer-independent endosomal cargo 1276 recycling

VPS29, a tweak tool of endosomal recycling

Architecture and mechanism of 1280 metazoan retromer:SNX3 tubular coat assembly

Structure of Vps26B and mapping of its interaction with the retromer protein 1282 complex

A novel mammalian retromer component

Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic 1285 Opportunities

Dysregulation of intracellular trafficking and endosomal sorting in

Alzheimer's disease: controversies and unanswered questions

Cell-penetrating peptide inhibits retromer-mediated 1289 human papillomavirus trafficking during virus entry

The retromer complex system in a transgenic mouse model of AD: influence of 1291 age

Cholera toxin inhibits SNX27-retromer-mediated delivery of cargo proteins to the 1293 plasma membrane

VPS35 regulates tau phosphorylation and neuropathology in tauopathy. Mol 1295 Psychiatry

VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's

What are pharmacological chaperones and why are they interesting?

Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein 1301 Surfaces and Probe Protein-Protein Interactions

Targeting intracellular protein-protein interactions with cell-1303 permeable cyclic peptides

Cyclic peptide therapeutics: past, present and future

Macrocyclic Peptides as Drug Candidates: Recent Progress and 1307 Remaining Challenges

Orally Absorbed Cyclic Peptides

Nonproteinogenic deep mutational scanning of linear and cyclic 1310 peptides

Strategies for transitioning macrocyclic peptides to cell-1312 permeable drug leads

A large family of endosome-1314 localized proteins related to sorting nexin 1

Vps29 has a phosphoesterase 1316 fold that acts as a protein interaction scaffold for retromer assembly

Phosphoinositide binding by the SNX27 FERM domain regulates its localization at 1319 the immune synapse of activated T-cells

A molecular code for endosomal recycling of phosphorylated cargos by the 1321 SNX27-retromer complex

Labeling Proteins Inside Living Cells Using External Fluorophores for 1323

Retromer has a selective function in cargo sorting via endosome transport carriers

How good are my data and what is the resolution?

Phaser crystallographic software

PHENIX: a comprehensive Python-based system for macromolecular structure 1331 solution

MolProbity: all-atom structure validation for macromolecular crystallography

T-Coffee: A novel method for fast and accurate multiple 1335 sequence alignment

ConSurf 2016: an improved methodology to estimate and visualize 1337 evolutionary conservation in macromolecules

Dali server: conservation mapping in 3D

Leginon: An automated system for acquisition of images from vitreous ice 1341 specimens

Gctf: Real-time CTF determination and correction

New tools for automated high-resolution cryo-EM structure determination in 1344 RELION-3

UCSF Chimera--a visualization system for exploratory research and analysis

Molecular Basis for Membrane Recruitment by 1348 the PX and C2 Domains of Class II Phosphoinositide 3-Kinase-C2alpha

HeLa cells transiently expressing SNX1-mCherry were exposed to SLO at 37°C for 9 min before incubating with the cyclic peptide RT-D3-FITC or RT-L4-FITC on ice for 5 min. Permeabilized cells were recovered in the recovery medium containing Hoechst 33342 for 20 min, then fixed in 4% PFA. The negative control (-SLO) shows no labeling of intracellular structures. Scale bar, 10 μm. Graphs show the fluorescence intensity of RT-D3-FITC or RT-L4-FITC in HeLa cells (means ± SEM). Two-tailed Student

HeLa cells transiently expressing Vps35-mCherry were labeled by SLO-delivered cyclic peptide RT-D3-FITC or RT-L4-FITC

RT-L4-FITC, or DMF control were incubated in recovery medium for 2 h, fixed in ice-cold methanol, and co-immunolabeled with antibodies against endogenous TBC1D5 and SNX1, followed by Alexa Fluor-conjugated fluorescent secondary antibodies. Scale bar, 10 μm. The colocalization between TBC1D5 and SNX1 was quantified by Pearson's correlation coefficient and represented in the graph (means ± SEM). Two-tailed Student's t-test was utilized to determine the statistical significance (n=3). ****